Cognition Therapeutics Inc.
Johnson & Johnson
Eisai Co. Ltd
Biogen Inc.
Roche Holding AG
Alector LLC
Neuro-Bio Ltd
Eli Lilly and Company
TauRx
Treventis Corporation
GE Healthcare
Novartis AG
Accera
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Alzheimers Disease Drugs and Diagnostics Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Alzheimers Disease Drugs and Diagnostics Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Alzheimers Disease Drugs and Diagnostics Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Alzheimers Disease Drugs and Diagnostics Market-Segmentation by Type
5.1 Drugs
5.2 Diagnostics
6 Global Alzheimers Disease Drugs and Diagnostics Market-Segmentation by Application
6.1 Hospital
6.2 Clinics
7 Global Alzheimers Disease Drugs and Diagnostics Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Cognition Therapeutics Inc.
8.1.1 Cognition Therapeutics Inc. Profile
8.1.2 Cognition Therapeutics Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Cognition Therapeutics Inc. Product/Solution Launches and Enhancements Analysis
8.1.4 Cognition Therapeutics Inc. Business Overview/Recent Development/Acquisitions
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Profile
8.2.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
8.2.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.3 Eisai Co. Ltd
8.3.1 Eisai Co. Ltd Profile
8.3.2 Eisai Co. Ltd Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Eisai Co. Ltd Product/Solution Launches and Enhancements Analysis
8.3.4 Eisai Co. Ltd Business Overview/Recent Development/Acquisitions
8.4 Biogen Inc.
8.4.1 Biogen Inc. Profile
8.4.2 Biogen Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Biogen Inc. Product/Solution Launches and Enhancements Analysis
8.4.4 Biogen Inc. Business Overview/Recent Development/Acquisitions
8.5 Roche Holding AG
8.5.1 Roche Holding AG Profile
8.5.2 Roche Holding AG Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Roche Holding AG Product/Solution Launches and Enhancements Analysis
8.5.4 Roche Holding AG Business Overview/Recent Development/Acquisitions
8.6 Alector LLC
8.6.1 Alector LLC Profile
8.6.2 Alector LLC Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Alector LLC Product/Solution Launches and Enhancements Analysis
8.6.4 Alector LLC Business Overview/Recent Development/Acquisitions
8.7 Neuro-Bio Ltd
8.7.1 Neuro-Bio Ltd Profile
8.7.2 Neuro-Bio Ltd Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Neuro-Bio Ltd Product/Solution Launches and Enhancements Analysis
8.7.4 Neuro-Bio Ltd Business Overview/Recent Development/Acquisitions
8.8 Eli Lilly and Company
8.8.1 Eli Lilly and Company Profile
8.8.2 Eli Lilly and Company Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Eli Lilly and Company Product/Solution Launches and Enhancements Analysis
8.8.4 Eli Lilly and Company Business Overview/Recent Development/Acquisitions
8.9 TauRx
8.9.1 TauRx Profile
8.9.2 TauRx Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 TauRx Product/Solution Launches and Enhancements Analysis
8.9.4 TauRx Business Overview/Recent Development/Acquisitions
8.10 Treventis Corporation
8.10.1 Treventis Corporation Profile
8.10.2 Treventis Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Treventis Corporation Product/Solution Launches and Enhancements Analysis
8.10.4 Treventis Corporation Business Overview/Recent Development/Acquisitions
8.11 GE Healthcare
8.11.1 GE Healthcare Profile
8.11.2 GE Healthcare Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 GE Healthcare Product/Solution Launches and Enhancements Analysis
8.11.4 GE Healthcare Business Overview/Recent Development/Acquisitions
8.12 Novartis AG
8.12.1 Novartis AG Profile
8.12.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Novartis AG Product/Solution Launches and Enhancements Analysis
8.12.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.13 Accera
8.13.1 Accera Profile
8.13.2 Accera Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Accera Product/Solution Launches and Enhancements Analysis
8.13.4 Accera Business Overview/Recent Development/Acquisitions
9 Global Alzheimers Disease Drugs and Diagnostics Market-Segmentation by Geography
10 North America
10.1 North America Alzheimers Disease Drugs and Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Alzheimers Disease Drugs and Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Alzheimers Disease Drugs and Diagnostics Production Analysis from 2015-2020
10.4 North America Alzheimers Disease Drugs and Diagnostics Consumption Analysis from 2015-2020
10.5 North America Alzheimers Disease Drugs and Diagnostics Import and Export from 2015-2020
10.6 North America Alzheimers Disease Drugs and Diagnostics Value, Production and Market Share by Type (2015-2020)
10.7 North America Alzheimers Disease Drugs and Diagnostics Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Alzheimers Disease Drugs and Diagnostics by Country (United States, Canada)
10.8.1 North America Alzheimers Disease Drugs and Diagnostics Sales by Country (2015-2020)
10.8.2 North America Alzheimers Disease Drugs and Diagnostics Consumption Value by Country (2015-2020)
10.9 North America Alzheimers Disease Drugs and Diagnostics Market PEST Analysis
11 Europe
11.1 Europe Alzheimers Disease Drugs and Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Alzheimers Disease Drugs and Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Alzheimers Disease Drugs and Diagnostics Production Analysis from 2015-2020
11.4 Europe Alzheimers Disease Drugs and Diagnostics Consumption Analysis from 2015-2020
11.5 Europe Alzheimers Disease Drugs and Diagnostics Import and Export from 2015-2020
11.6 Europe Alzheimers Disease Drugs and Diagnostics Value, Production and Market Share by Type (2015-2020)
11.7 Europe Alzheimers Disease Drugs and Diagnostics Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Alzheimers Disease Drugs and Diagnostics by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Alzheimers Disease Drugs and Diagnostics Sales by Country (2015-2020)
11.8.2 Europe Alzheimers Disease Drugs and Diagnostics Consumption Value by Country (2015-2020)
11.9 Europe Alzheimers Disease Drugs and Diagnostics Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Alzheimers Disease Drugs and Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Alzheimers Disease Drugs and Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Alzheimers Disease Drugs and Diagnostics Production Analysis from 2015-2020
12.4 Asia-Pacific Alzheimers Disease Drugs and Diagnostics Consumption Analysis from 2015-2020
12.5 Asia-Pacific Alzheimers Disease Drugs and Diagnostics Import and Export from 2015-2020
12.6 Asia-Pacific Alzheimers Disease Drugs and Diagnostics Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Alzheimers Disease Drugs and Diagnostics Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Alzheimers Disease Drugs and Diagnostics by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Alzheimers Disease Drugs and Diagnostics Sales by Country (2015-2020)
12.8.2 Asia-Pacific Alzheimers Disease Drugs and Diagnostics Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Alzheimers Disease Drugs and Diagnostics Market PEST Analysis
13 Latin America
13.1 Latin America Alzheimers Disease Drugs and Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Alzheimers Disease Drugs and Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Alzheimers Disease Drugs and Diagnostics Production Analysis from 2015-2020
13.4 Latin America Alzheimers Disease Drugs and Diagnostics Consumption Analysis from 2015-2020
13.5 Latin America Alzheimers Disease Drugs and Diagnostics Import and Export from 2015-2020
13.6 Latin America Alzheimers Disease Drugs and Diagnostics Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Alzheimers Disease Drugs and Diagnostics Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Alzheimers Disease Drugs and Diagnostics by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Alzheimers Disease Drugs and Diagnostics Sales by Country (2015-2020)
13.8.2 Latin America Alzheimers Disease Drugs and Diagnostics Consumption Value by Country (2015-2020)
13.9 Latin America Alzheimers Disease Drugs and Diagnostics Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Alzheimers Disease Drugs and Diagnostics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Alzheimers Disease Drugs and Diagnostics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Alzheimers Disease Drugs and Diagnostics Production Analysis from 2015-2020
14.4 Middle East & Africa Alzheimers Disease Drugs and Diagnostics Consumption Analysis from 2015-2020
14.5 Middle East & Africa Alzheimers Disease Drugs and Diagnostics Import and Export from 2015-2020
14.6 Middle East & Africa Alzheimers Disease Drugs and Diagnostics Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Alzheimers Disease Drugs and Diagnostics Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Alzheimers Disease Drugs and Diagnostics by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Alzheimers Disease Drugs and Diagnostics Sales by Country (2015-2020)
14.8.2 Middle East & Africa Alzheimers Disease Drugs and Diagnostics Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Alzheimers Disease Drugs and Diagnostics Market PEST Analysis
15 Future Forecast of the Global Alzheimers Disease Drugs and Diagnostics Market from 2020-2028
15.1 Future Forecast of the Global Alzheimers Disease Drugs and Diagnostics Market from 2020-2028 Segment by Region
15.2 Global Alzheimers Disease Drugs and Diagnostics Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Alzheimers Disease Drugs and Diagnostics Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
